DS79932728 is a Potent, Orally Available G9a/GLP Inhibitor for Treating β‑Thalassemia and Sickle Cell Disease.

This product can not be ordered from your electronic catalog. A quotation will be created for this reference, would you like to continue? In this case, make sure that you have filled in the desired quantity
Email